Not all treatments and medications are routinely funded by the NHS. This is because the effectiveness of certain procedures and medications can vary amongst patients and in some cases do more harm than good.
This means that NHS Clinical Commissioning Groups (CCGs), as local guardians and commissioners of the NHS, must make decisions about which healthcare services it will and will not routinely provide under the NHS in its area.
In order to provide the best care and treatment and to make best of use of its limited resources, each CCG has developed clinical policies, which it uses to make these decisions. The clinical policies identify the treatments that will not normally be provided and where prior approval is often needed before such treatments can take place.
The eight Clinical Commissioning Groups in Lancashire are working together to review their clinical policies. They are seeking to make clinical decisions consistent and fair across Lancashire. As part of this process clinical policies are being amended and updated and brought into line wherever possible across the CCGs.
This document identifies the latest draft clinical policies to go through this process. There are 6 clinical policies listed in the table below. The table consists of the following information:
- (Embedded) links to each draft policy,
- A level of change document (which identifies what, if anything, has been changed from the previous policy);
- Links to surveys for each policy. You are encouraged to read the draft policy document for any policy you wish to comment upon before completing the relevant survey. The policy documents (apart from the new policy on insulin pumps and glucose monitoring devices) are only a few pages long.
You will notice that the table is colour-coded. This has been done to help you to easily identify the level of change from the previous policy. This may help you decide which policies to give feedback on if you do not wish to consider them all. A key to the colour-coding is included below.
If you would prefer to have a hard-copy of a draft policy document and/or of the relevant survey they can be printed from this webpage or by contacting the Clinical Commissioning Group on
Feedback/completion of the survey on all but the draft policy on insulin pumps must be completed by Friday 7 April. Feedback on the new draft policy on insulin pumps and glucose monitoring devices must be provided by Friday 28 April.
|RED||Important/significant change – impact on many or all patients|
|PURPLE||A number of criteria changes or amendments and, non-criteria changes to the policy with impact on a range of patients|
|AMBER||A few criteria changes which are likely to impact on some patients|
|ORANGE||A few limited changes (little or no impact on
|LIGHT BLUE||New policy for this CCG|